Amneal Pharmaceuticals, Inc. (AMRX) Current Reports & Earnings Releases
Upcoming
- 2026-10-29 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-10 | 8-K | Material Agreement, Acquisition or Disposition, Direct Financial Obligation, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-03 | 8-K | Material Agreement | SEC |
| 2026-07-31 | 8-K | Shareholder Vote Results | SEC |
| 2026-07-30 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-22 | 8-K | Material Agreement, Results of Operations, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-27 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-03 | 8-K | Material Agreement, Direct Financial Obligation | SEC |
| 2026-01-28 | 8-K | Other Events | SEC |
| 2026-01-13 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2025-10-30 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-01 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-07-24 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-21 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-21 | 8-K | Results of Operations, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-08 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-02 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-06 | 8-K | Officer / Director Changes | SEC |
| 2025-02-28 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-15 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2024-11-08 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-09 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-03 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-01 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-10 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.